Tonix Pharmaceuticals Holding Corp. Company Profile (NASDAQ:TNXP)

Analyst Ratings

Consensus Ratings for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.67 (433.33% upside)

Analysts' Ratings History for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
Show:
DateFirmActionRatingPrice TargetActions
6/20/2016Oppenheimer Holdings Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2016Cantor FitzgeraldUpgradeSpeculative Buy -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2016Roth CapitalReiterated RatingBuy$7.50 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/30/2015Janney Montgomery ScottReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/9/2016Q1($0.63)($0.74)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2016Q4($0.66)($0.71)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.65)($0.73)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q115($0.54)($0.71)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2015Q414($0.81)($0.83)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014Q314($0.69)($0.71)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2014Q214($0.53)($0.61)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/13/2014Q114($0.35)($0.59)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/31/2014($0.46)($0.74)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.58)($0.58)($0.58)
Q2 20163($0.63)($0.49)($0.56)
Q3 20162($0.49)($0.31)($0.40)
Q4 20162($0.45)($0.21)($0.33)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/22/2016Seth LedermanCEOBuy20,000$2.08$41,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/21/2016Bradley SaengerCFOBuy2,000$2.00$4,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/21/2016Bruce DaughertyInsiderBuy100,000$2.00$200,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/21/2016John B RhodesDirectorBuy25,000$2.00$50,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2016Gregory M SullivanInsiderBuy20,000$2.50$50,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2016Ernest MarioDirectorBuy31,042$2.30$71,396.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/11/2016Ernest MarioDirectorBuy8,210$2.24$18,390.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2016Seth LedermanCEOBuy8,000$2.44$19,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2016Ernest MarioDirectorBuy75,000$2.29$171,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/30/2015Gregory M SullivanInsiderBuy5,000$5.18$25,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/28/2015Gregory M SullivanInsiderBuy4,694$5.95$27,929.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/25/2015Seth LedermanCEOBuy6,000$6.50$39,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2015Ernest MarioDirectorBuy10,000$6.05$60,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2015Ernest MarioDirectorBuy1,468$6.40$9,395.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/24/2015Ernest MarioDirectorBuy2,532$6.20$15,698.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2015Ernest MarioDirectorBuy6,000$6.64$39,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2015Ernest MarioDirectorBuy15,000$6.93$103,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/17/2015John B RhodesDirectorBuy6,000$7.50$45,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/17/2015Leland GershellCFOBuy1,000$7.50$7,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2015Gregory M SullivanInsiderBuy4,500$8.38$37,710.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2015Seth LedermanCEOBuy2,000$7.02$14,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2015Seth LedermanCEOBuy2,000$7.24$14,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2015Seth LedermanCEOBuy2,000$6.95$13,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015Charles E Iv MatherDirectorBuy1,000$6.80$6,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2015Seth LedermanCEOBuy2,000$6.48$12,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2015Ernest MarioDirectorBuy4,000$6.57$26,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2015Seth LedermanCEOBuy2,000$6.27$12,540.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2015Ernest MarioDirectorBuy30,000$5.85$175,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2015Leland GershellCFOBuy5,000$5.85$29,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/27/2013Charles E Iv MatherDirectorBuy1,000$3.65$3,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)
DateHeadline
07/23/16 10:39 AMEquity Roundup: Stock Performance Focus on Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Press Telegraph
07/23/16 10:39 AMBroker Outlook For Tonix Pharmaceuticals Holding Corp. (TNXP) - Fiscal Standard
07/20/16 07:54 PMTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/18/16 08:35 AMTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Wall Street Analyst Recommendation Outlook - TGP
07/17/16 06:09 PMTonix Pharmaceuticals Holding Corp. (TNXP) Broker Price Targets For The Coming Week - Fiscal Standard
07/16/16 06:09 PMShares Experiencing a Downtrend: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - TGP
07/16/16 06:09 PMTonix Pharmaceuticals Holding Corp. Stock Momentum Hits Extreme Weakness - CML News
07/16/16 06:09 PMShares Moving Down on the Week: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Engelwood Daily
07/14/16 10:29 AMNew Broker Ratings For Tonix Pharmaceuticals Holding Corp. (TNXP) - FTSE News
07/14/16 10:29 AMTonix Pharmaceuticals Holding Corp. Has Another Very Weak Trading Session - Consumer Eagle
07/14/16 10:29 AMTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/12/16 07:05 PMTonix Pharmaceuticals Announces Full Exercise and Closing of Underwriters’ Over-Allotment Option
07/10/16 05:59 PMIs $12 Within Reach For Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)? - Investor Newswire
07/08/16 06:46 PMTonix Pharmaceuticals Holding Corp. Realized Volatility Hits Extreme Level - CML News
07/07/16 03:05 PMTonix Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference - [GlobeNewswire] - NEW YORK, July 07, 2016-- Tonix Pharmaceuticals Holding Corp., which is developing next-generation medicines for fibromyalgia and post-traumatic stress disorder, announced today that it will present at ...
07/05/16 06:30 PMTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Expected to Reach Highs Of $12 - Investor Newswire
07/03/16 08:22 AMCompany Stock Lower on the Week Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Engelwood Daily
06/30/16 07:00 PMUpdate on Stock Volatility for: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Engelwood Daily
06/29/16 03:03 PMTONIX PHARMACEUTICALS HOLDING CORP. Files SEC form 8-K/A, Regulation FD Disclosure, Financial Statements and Exhibits -
06/28/16 06:46 PMStrong Sell Calls Recommendations For Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) At 0 - Investor Newswire
06/28/16 06:46 PMCovering the Bases on Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP): Where is the Stock Going? - Press Telegraph
06/28/16 06:46 PMCheck on Share Volatility: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Engelwood Daily
06/28/16 06:46 PMNext Weeks Broker Price Targets For Tonix Pharmaceuticals Holding Corp. (TNXP) - Fiscal Standard
06/28/16 04:16 PMTONIX PHARMACEUTICALS HOLDING CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
06/25/16 10:30 AMShare Volatility Check for: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Press Telegraph
06/25/16 10:30 AMTonix Pharmaceuticals Holding Corp. (TNXP) Current Analyst Ratings - Fiscal Standard
06/23/16 07:36 PMWhat The Future Holds For Tonix - Seeking Alpha
06/23/16 09:25 AMChief Executive Officer of Tonix Pharmaceuticals Holding C (NASDAQ:TNXP), Lederman Seth, buys 20,000 shares worth $41,500
06/22/16 07:45 AMCan You Catch These 6 Stocks Under $10 on Their Way Up? -
06/22/16 06:55 AMKingsway Financial Services Inc. (USA) (KFS) and Two Pharmaceutical Companies Register Insider Buying -
06/21/16 06:21 PMTONIX PHARMACEUTICALS HOLDING CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
06/21/16 06:21 PMDirector of Tonix Pharmaceuticals Holding C (NASDAQ:TNXP), Rhodes John B, buys 25,000 shares worth $50,000
06/20/16 06:24 PMStrong Buy Calls Count For Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) At 3 - Investor Newswire
06/17/16 07:00 AMTonix Pharmaceuticals to Present at the JMP Securities Life Sciences Conference - [GlobeNewswire] - NEW YORK, June 17, 2016-- Tonix Pharmaceuticals Holding Corp., which is developing next-generation medicines for fibromyalgia and post-traumatic stress disorder, announced today that Seth Lederman, M.D., ...
06/16/16 10:59 AMTONIX PHARMACEUTICALS HOLDING CORP. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
06/16/16 10:59 AMTonix Pharma's stock plummets after stock offering prices at deep discount
06/16/16 10:59 AMTonix Pharmaceuticals Prices Secondary Offering
06/13/16 02:40 PMTNXP: A Closer Look at Data from the AtEase Trial of TNX-102 SL in Military-Related PTSD… -
06/12/16 06:55 PMTrend Of Rating Given To Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Investor Newswire
06/10/16 09:56 AMCan Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Meet Analysts Expectations? - Stocks Daily
06/09/16 07:23 PMTonix Pharmaceuticals (TNXP) Announces Presentation of Encouraging TNX-102 SL Phase 2b Data in Fibromyalgia
06/09/16 09:56 AMTonix Pharmaceuticals Presents at EULAR Results of a Retrospective Analysis from the Phase 2b BESTFIT Clinical Study of TNX-102 SL in Fibromyalgia
06/07/16 07:07 PMTONIX PHARMACEUTICALS HOLDING CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
06/03/16 06:00 AMTonix Pharmaceuticals to Present at the 2016 BIO International Convention - [GlobeNewswire] - NEW YORK, June 03, 2016-- Tonix Pharmaceuticals Holding Corp., which is developing next-generation medicines for fibromyalgia and post-traumatic stress disorder, announced today that Seth Lederman, M.D., ...
06/03/16 05:05 AMTONIX PHARMACEUTICALS HOLDING CORP. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Ye -
06/02/16 07:22 PMTonix Pharmaceuticals Holding Corp. (TNXP) – Research Analysts' Weekly Ratings Updates - Let Me Know About This - Business Finance NewsTonix Pharmaceuticals Holding Corp. (TNXP) – Research Analysts' Weekly Ratings UpdatesLet Me Know About ThisTonix Pharmaceuticals Holding Corp. logo Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) recently received a number of ratings updates from brokerages and research firms: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) traded up 4.51% ...Buy, Sell Or Hold Rating For Tonix Pharmaceuticals Holding Corp. (TNXP)?Share Trading NewsTop Stock in Session: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)The PostBroker Changes For Tonix Pharmaceuticals Holding Corp. (TNXP)Risers & FallersFranklin Independent -HNN -Benchmark Monitorall 12 news articles »
06/02/16 10:05 AMStock Review and Earnings Check on Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - HNN - Stock Review and Earnings Check on Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)HNNCompany earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) to report quarterly EPS of $-0.57. The company's next earnings report is expected to ...and more »
06/01/16 09:51 AMCoca-Cola Enterprises, Inc. (NYSE:CCE) Plummeted -24.71%: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP ... - KC Register - Coca-Cola Enterprises, Inc. (NYSE:CCE) Plummeted -24.71%: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP ...KC RegisterTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) traded 643170 shares and its share price advanced 6.55% to close at $2.44. Company has 3.00% insider ownership. Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) quarterly performance is ...
05/31/16 09:55 AMTonix Pharmaceuticals (TNXP) Announces Presentation of TNX-102 SL Phase 2 Data in PTSD; Four SAEs Noted - StreetInsider.com - Tonix Pharmaceuticals (TNXP) Announces Presentation of TNX-102 SL Phase 2 Data in PTSD; Four SAEs NotedStreetInsider.comTonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) announced the presentation of positive results from its Phase 2 dose-finding clinical study (AtEase Study) of TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for the treatment of military-related ...Tonix Pharmaceuticals Shares Surge 15% Pre-Bell on Positive PTSD Treatment Study Results (NASDAQ:TNXP)Sonoran Weekly Reviewall 2 news articles »
05/31/16 09:55 AMGlycoMimetics, Inc. (NASDAQ:GLYC) rose 2.79%: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP ... - KC Register - GlycoMimetics, Inc. (NASDAQ:GLYC) rose 2.79%: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP ...KC RegisterTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced that it will present positive data from the Phase 2 dose-finding clinical study of TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for the treatment of military-related PTSD (AtEase Study).

Social

About Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp. logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TNXP
  • CUSIP:
Key Metrics:
  • Previous Close: $1.96
  • 50 Day Moving Average: $2.19
  • 200 Day Moving Average: $2.95
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $37.78M
  • Beta: 2.66
  • Current Year EPS Consensus Estimate: $-2.04 EPS
  • Next Year EPS Consensus Estimate: $-1.39 EPS
Additional Links:
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Chart for Saturday, July, 23, 2016